ArticleOncotarget2020

Immune-stimulatory (TK/Flt3L) gene therapy opens the door to a promising new treatment strategy against brainstem gliomas.

Syed M Faisal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.